Neuroblastomas that might benefit from mass screening at 6 months of age in Japan

Pediatr Blood Cancer. 2007 Feb;48(2):245-6; author reply 247. doi: 10.1002/pbc.20882.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Humans
  • Infant
  • Japan / epidemiology
  • Mass Screening*
  • Neuroblastoma / diagnosis*
  • Neuroblastoma / epidemiology